POSTECH 생명과학과

News/Event

News/Event
Photo News
Photo News

Genexine delivers a donation certificate for Genexine Research Fellows…

File
  • No File
  • View242
  • Writer최고관리자
  • 2020-11-30

본문

5bd5ab9f840addfb497001c956aa3cfb_1606715322_7378.JPG
5bd5ab9f840addfb497001c956aa3cfb_1606715328_7995.JPG
5bd5ab9f840addfb497001c956aa3cfb_1606715333_5903.JPG
5bd5ab9f840addfb497001c956aa3cfb_1606715335_2005.JPG
5bd5ab9f840addfb497001c956aa3cfb_1606715346_5138.JPG
5bd5ab9f840addfb497001c956aa3cfb_1606715349_3512.JPG
5bd5ab9f840addfb497001c956aa3cfb_1606715351_6214.JPG

 

POSTECH thanks Genexine for donating KRW 250 million won
Genexine made a five-year pledge of 250 million won (USD 226,000) as research funds to POSTECH.
The donation will be used to promote scholarship programs for undergraduate students who take Research Participation or Undergraduate Thesis courses in the Department of Life Sciences.
Genexine, which started as an in-school venture company in 1999, has grown into a company with a market value of 3 trillion won.
Genexine is currently developing COVID-19 vaccines and treatments, along with about 10 other new drug candidate materials. POSTECH believes that Genexine's efforts will help save humanity from various threats.

 


Top